Data / Form D filings / MANNKIND CORP
MANNKIND CORP: Form D filing
MANNKIND CORP, a pharmaceuticals company in Valencia, CA, filed a Form D with the SEC in 2013. The latest, on July 15, 2013, reports $58.9 million sold of a $178.9 million offering to 2 investors.
Find out what MANNKIND CORP does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 28903 NORTH AVENUE PAINE, Valencia, CA, 91355
- Phone
- (661) 775-5300
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 899460
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 15, 2013 | New notice | $178,900,000 | $58,900,000 | $120,000,000 | 2 | Jul 1, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| JUERGEN A MARTENS | Executive Officer | |
| HAKAN S EDSTROM | Executive Officer, Director | |
| KENT B KRESA | Director | |
| DIANE M PALUMBO | Executive Officer | |
| MATTHEW J PFEFFER | Executive Officer | |
| RONALD B CONSIGLIO | Director | |
| MICHAEL B FRIEDMAN | Director | |
| DAVID B THOMSON | Executive Officer | |
| HENRY L NORDHOFF | Director | |
| ALFRED E MANN | Executive Officer, Director | |
| DAVID H MACCALLUM | Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Jul 15, 2013 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what MANNKIND CORP reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.